Substituted dihydrobenzopyrans

ABSTRACT

The invention relates to compounds of the formula: ##STR1## which are useful as leukotriene D 4  (LTD 4 ) inhibitors and therefore useful in the treatment of allergies and inflammatory conditions.

This is a division of application Ser. No. 06/560,355, filed Dec. 12,1983, now abandoned, which is a continuation-in-part of Ser. No.06/520,973, filed Aug. 8, 1983, abandoned.

BACKGROUND OF THE INVENTION

(a) Field of the Invention

This invention in its broadest aspect, relates to metabolic inhibitors.In particular the invention relates to novel compounds of Formula Iwhich are inhibitors of leukotriene D₄ (LTD₄) and therefore useful toprevent or alleviate the symptoms or conditions associated with LTD₄such s allergic reactions and inflammatory conditions.

LTD₄ is a product of the 5-lipoxygenase pathway and is the major activeconstituent of slow reacting substance of anaphylaxis (SRS-A) in humansand guinea pigs, Lewis et al., Nature USA, 293: 103-108, (1981). It is apotent bronchoconstrictor that is released during allergic reactions.Because antihistamines are ineffective in the management of asthma it isbelieved that SRS-A mediates bronchoconstriction resulting from anallergic attack. SRS-A is also a potent inducer of vascularpermiability, and it also may be involved in other inflammatoryconditions such as rheumatoid arthritis.

(b) Information Disclosure

Appleton et al., J. Med. Chem. 20, 371-379 (1977) discloses a series ofchromone-2-carboxylic acids which are antagonists of SRS-A. Specificallysodium7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylate(FPL 55712), appears to be the first reported specific antagonist ofSRS-A and LTD₄.

SUMMARY OF THE INVENTION

The invention relates to compounds of the formula: ##STR2## wherein Zis: (a) --(CH₂)_(n) --; or

(b) --(CH₂)_(p) --CH═CH--(CH₂)_(q) --;

(CH₂)_(r)

(c) --(CH₂)_(s) --CH--CH--(CH₂)_(t) ;

(d) --CO-(CH₂)_(w) --; or

(e) --CHOH--(CH₂)_(v) --

wherein 1 is an integer of from zero to 2 inclusive;

wherein m is an integer of from 2 to 6 inclusive;

wherein n is an integer of from 1 to 3 inclusive;

wherein p is an integer of from zero to 4 inclusive;

wherein q is an integer of from zero to 4 inclusive;

wherein p+q is equal to or less than 6;

wherein r is an integer of from 1 to 5 inclusive;

wherein s is an integer of from zero to 4 inclusive;

wherein t is an integer of from 0 to 4 inclusive;

wherein w is an integer of from 1 to 6 inclusive;

wherein v is an integer of from 1 to 6 inclusive;

wherein Y is:

(a) --H;

(b) ═H₂ ;

--H

(c) --OH; or

(d) ═O;

with the proviso that the double bond at the 3-4 position may be presentonly when Y is H;

wherein R₁, R₂, R₅ and R₆ are:

(a) alkyl of 1 to 6 carbon atoms, inclusive, each being the same ordifferent;

wherein R₃ is:

(a) alkyl of 1 to 6 carbon atoms, inclusive;

(b) --COOH; or

(c) --(CH₂)₁ COOR₅ ;

with the proviso that R₃ is hydrogen when Y is not ═O;

wherein R₄ is:

(a) hydrogen;

(b) --CO₂ H;

(c) --CO₂ R₆ ;

(d) --CONR₇ R₈ ; or

(e) --OH

wherein R₇ and R₈ are:

(a) hydrogen

(b) alkyl of 1 to 6 carbon atoms, inclusive; R₇ and R₈ each being thesame or different; or

(c) taken together to form a 5 or 6 member ring optionally substitutedby carboxylic acid or methylester thereof with the balance of themembers being carbon;

or the pharmacologically acceptable addition salts thereof.

Examples of alkyl of 1 to 6 carbon atoms inclusve are methyl, ethyl,propyl, butyl, pentyl, hexyl, and the isomeric forms thereof.

Salts of the acid forms of these compounds can be prepared byneutralization with the appropriate amount of an inorganic or organicbase such as sodium hydroxide, potassium hydroxide, calcium hydroxide,magnesium hydroxide, ammonia, trialkylamine, dialkylamine,monoalkylamine, dibasic amino acids, sodium acetate, potassium benzoate,triethanolamine and like bases.

LTD₄ causes bronchoconstriction when administered to humans and guineapigs. The bronchoconstriction has 2 components:, (a) a directstimulation of respiratory smooth muscle by LTD₄ and (b) an indirectcomponent through release of thromboxane A2 which in turn causescontraction of respiratory smooth muscle. Compounds of the inventionantagonize the direct component. The compounds are tested in vivo asfollows.

Adult male fasted Hartly guinea pigs weighing 300-350 g are pretreatedwith pyrilamine and indomethacin to block the bronchoconstrictureeffects of endogenous histamine and the synthesis of thromboxane A2respectively. Compounds of the invention are administered IV or IG atappropriate times prior to the IV administration of 2000 units of LTD₄.Intratracheal pressure is monitored prior to and subsequent to LTD₄ inanimals anesthetized with pentobarbital and attached to a rodentrespirator. Compounds which antagonize the direct component of LTD₄action on respiratory smooth muscle inhibit intratracheal insufflationpressure increases (P or=0.05) caused by LTD₄. FPL 55712 is used as acontrol.

The compounds can be administered in a number of dosage forms. Apreferred method of delivery would be oral or in such a manner so as tolocalize the action of the inhibitor. For example, for asthma, thecompounds could be inhaled using an aerosol or other appropriate spray.In an inflammatory condition such as rheumatoid arthritis the compoundscould be injected directly into the affected joint. The compounds couldalso be administered in oral unit dosage forms such as tablets,capsules, pills, powders or granules. They also may be administeredrectally or vaginally in such forms as suppositories. They may beintroduced in the forms of eyedrops, intraperitoneally, subcutaneously,or intramuscularly using forms known to the pharmaceutical art. For thetreatment of inflammatory allergic skin conditions, the compounds of thepresent invention may also be administered topically in the form ofointments, creams, gels or the like. Regardless of the route ofadministration selected, the compounds are formulated intopharmaceutically acceptable dosage forms by conventional methods knownto the pharmaceutical art.

An effective but non-toxic quantity of the compound is employed intreatment. The dosage regimen for inhibition of LTD₄ by the compounds ofthis invention is selected in accordance with a variety of factorsincluding the type, age, weight, sex, and medical condition of themammal, the particular disease and its severity, the route ofadministration and the particular compound employed. An ordinarilyskilled physician or veterinarian will readily determine and prescribethe effective amount of the compound to prevent or arrest the progressof the condition. In so proceeding, the physician or veterinarian couldemploy relatively low dosages at first, subsequently increasing the doseuntil a maximum response is obtained.

The compounds of this invention are prepared by the general methodsillustrated in Charts A to E. The various compounds and intermediatescan be readily modified by methods known to those skilled in the art.For example, esters can be hydrolyzed to corresponding carboxylic acids(and their respective addition salts), converted to corresponding amidesby appropriate reactions with amines, and reduced to alcohols by suchreagents as Lithium borohydride. Such products and intermediates can, ofcourse, be similarly interconverted.

As illustrated in Chart A, 2-hydroxyacetophenones of Formula XI reactreadily with ketones of Formula XII to afford fused ring compounds ofFormula XIII. Ketones, Formula XII, include ketoesters in which Z isalkylene or alkenylene and R₄ is alkoxycarbonyl. An example of such aketoester is ethyl levulinate. Preferred condensation and cyclizationconditions include heating Formulas XI and XII at reflux in toluene, inthe presence of a base such as pyrrolidine, with provisions for theremoval of water with an apparatus such as a Dean-Stark trap.Intermediates of Formula XIII thus formed may be used in reactions ofChart B without further modification or they may be converted to relatedintermediates, Formula XIV, by methods known to those skilled in theart. For example, hydrogenation over palladium on carbon will reduce theketo function of Formula XIII to the corresponding dihydrobenzopyran,Formula XIV (Y=H₂). Partial hydrogenation would afford correspondinghydroxyl compounds (Y=H, OH).

As illustrated in Chart B, compounds of Formula XIV may be alkylatedunder basic conditions to form compounds of Formula XXI. Preferredreagents include dihaloalkanes, such as 1,3-dibromopropane and the like.Preferred conditions include reaction in dry dimethylformamide in thepresence of anhydrous potassium carbonate. Intermediates XXI aretypically purified by column chromatography on silica gel. Reaction ofthese intermediates with 2-hydroxyacetophenones of Formula XXII affordtitle compounds of this invention, Formula XXIII. Preferred conditionsinclude reaction in dry dimethylformamide in the presence of anhydrouspotassium carbonate. Alternatively, the reaction may be run under phasetransfer conditions.

Chart C illustrates preparation of compounds XXIII using a variation ofthe method of Chart B. 2-Hydroxyacetophenones of Formula XXII react withdihaloalkanes as described above (See Chart B) to form intermediates ofFormula XXXI. By the same general procedure employed in convertingFormula XIV to Formula XXI, compounds XXXI and XIV react to form thetitle compounds of this invention, Formula XXIII.

Chart D illustrates another route for preparing some of the compounds ofthis invention. Benzopyrones of Formula XLI, previously described in theliterature, can be reduced by catalytic hydrogenation to compounds ofFormula XLII, where Y may range from ═O to (H, OH) to H₂, which can befurther modified by methods known to those skilled in the art. Forexample, the hydroxyl compounds (Y═H, OH) can be dehydrated to formbenzopyrans of Formula XLIII. Methods include conversion to the mesylatederivatives, followed by elimination under basic conditions to formFormula XLIII. As another example, esters (R₄ ═COO(alkyl)) can bereduced with active metal hydrides, such as Lithium borohydride, to givecorresponding alcohols of Formula XLIV.

Chart E also illustrates another approach to preparing some of thecompounds of this invention. Compounds of Formula LI (in which R₁₁ maybe a protecting group to be removed for later elaboration or may consistof the ultimate aromatic side chain already prepared as generallydescribed above) are first treated with strong base in an unreactivesolvent. Preferred reagents include n-butyl lithium in tetrahydrofuran.Alkylation affords compounds of Formula LII. Examples of alkylatingreagents include simple alkyl halides or substituted alkyl halides, suchas iodoalkylcarboxylic ester, beta-unsaturated carboxylic esters (whichundergo conjugate additions), and many other reagents known to thoseskilled in the art. Further conversions of compounds LII can produceother derivatives, such as free carboxylic acids, Formula LIII, whichcan be formed by hydrolysis of compounds LII. Acylation of compounds LIunder similar conditions afford compounds of Formula LIV. Acylatingreagents include acyl halides or other activated acyl derivatives.Preferred reagents include substituted N-alkanoylimidazole derivatives.Compounds of Formula LIV can also be converted to other derivatives. Forexample, basic hydrolysis leads to decarboxylated compounds of FormulaLV.

The invention will appear more fully from the Examples which follow.These Examples are given by way of illustration only and are not to beconstrued as limiting the invention either in spirit or in scope, asmany modifications both in materials and methods will be apparent fromthis disclosure to those skilled in the art. In these examples,temperatures are given in degrees celcius (°C.) and quantities ofmaterials in grams and milliliters unless otherwise noted.

DESCRIPTION OF THE PREFERRED EMBODIMENTS s EXAMPLE 1 ethyl3-(3,4-dihydro-7-hydroxy-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)propanoate

A solution of 58.0 g (0.299 mole) of 2,4-dihydroxy-3-propylacetophenoneand 29.5 ml (0.36 mole) of pyrrolidine in 250 ml of toluene was heatedto reflux for three hours under a Dean-Stark trap. After cooling themixture, 68.2 ml (0.48 mole) of ethyl levulinate was added and themixture was refluxed for two hours. An additional 10 ml (0.12 mole) ofpyrrolidine was added and the mixture was refluxed overnight under aDean-Stark trap.

The reaction mixture was diluted with ethyl acetate and washedsuccessively with water, 2M hydrochloric acid, water and brine. It wasthen dried over MgSO₄, filtered, and evaporated to dryness. The residuewas chromatographed on silica gel using 30% ethyl acetate/hexane aseluent to give 35.5 g of the title ester, mp. 92°-94°. Structureassignment was confirmed by nmr and infrared spectra.

IR(CHCl₃): 1665, 1730 cm⁻¹ ##STR4##

EXAMPLE 21-[3-(3,4-dihydro-7-hydroxy-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-1-oxopropyl]pyrrolidine

Other chromatographic fractions of Example 1 afforded 30 g of the titleamide, m.p. 182°-184°. Structure assignment was confirmed by nmr andinfrared spectra and by elemental analysis.

IR(KBr): 1615, 1675 cm⁻¹

Analysis. Calcd. for C₂₀ H₂₇ NO₄ : C, 69.54; H, 7.88; N, 4.05. Found: C,69.22; H, 7.93; N, 3.97. ##STR5##

EXAMPLE 33-(3,4-dihydro-7-hydroxy-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)propanoicacid

To a mixture of 20.0 g (103 mmole) of 2,4-dihydroxy-3-propylacetophenoneand 15.5 g (134 mmole) of methyl levulinate in 100 ml of dry toluene wasadded by syringe 21.5 ml (ca. 260 mmole) of pyrrolidine. After stirringfor one hour the solution was heated on a steam bath for four hours andallowed to cool. The toluene solution was washed with water and 2N NaOH.The basic solution was acidified and extracted with diethyl ether, whichin turn was extracted with saturated sodium bicarbonate. The basicaqueous extract was neutralized with dilute hydrochloric acid and againextracted with diethyl ether. After drying, the solution wasconcentrated at reduced pressure to an oil which crystallized to thetitle compound, m.p. 152°-153°.

Analysis calcd. for C₁₆ H₂₀ O₅ : C, 65.74; H, 6.90. Found: C. 65.24; H,6.86. ##STR6##

EXAMPLE 4 methyl3-(3,4-dihydro-7-hydroxy-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)propanoate

A mixture of the title compound of Example 3 (4.3 g, 14.7 mmole), 6 mlof trimethylorthoformate, and 1.4 ml of sulfuric acid was stirred atroom temperature for two hours. The reaction mixture was poured ontostirred ice/water and extracted with ethyl acetate. The organic phasewas washed with water, dried over magnesium sulfate, and concentrated toan oil. The oil was purified by chromatography on silica gel, giving 3.7g of the title compound as a crystalline solid, m.p. 101.5°-102.5°.Structure assignment was consistent with nmr and infrared spectra.##STR7##

EXAMPLE 5 4-(3-bromopropoxy)-2-hydroxy-3-propylaceto-phenone

To a mixture of 50.0 g (257 mmole) of2,4-dihydroxy-3-propylacetophenone, 87.4 g (257 mmole) of tetrabutylhydrogen sulfate, and 52.2 ml (ca. 514 mmole) of dibromopropane in 250ml of dichloromethane was added 225 ml (450 mmole) of 2N NaOH. Themixture was then heated at reflux for about 30 min. and allowed to cool.After concentrating the reaction mixture under vacuum, the residue wastriturated with diethyl ether, and the ether solution was filtered andconcentrated to dryness. After purification by column chromatography onsilica gel, the title compound was isolated and used in subsequentreactions without further characterization. ##STR8##

EXAMPLE 6 methyl3-[7-[3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoate

A mixture of 1.9 g (6.2 mmole) of the ester product of Example 4, 2.2 g(6.8 mmole) of the title product of Example 5, and 1.8 g (13 mmole) ofanhydrous potassium carbonate in 30 ml of dry dimethylformamide wasstirred for 16 hours at room temperature. The inorganic salts wereremoved by filtration and the dimethylformamide was evaporated in vacuo.The residue was dissolved in ethyl acetate and additional inorganicsalts were filtered. The filtrate was evaporated and the residue waschromatographed on silica gel using 7% ethyl acetate/toluene as eluentto afford 2.5 g of the title compound, mp. 73°-74.5°. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

nmr (CDCl₃): δ(ppm) 0.89 (t, J=7.5 Hz, 6H, propyl CH₃ 's); 1.24 (t, J=7Hz, 3H, ester CH₃); 1.35 (s, 3H, 2-methyl protons); 2.55 (s, 3H, acetylCH₃); 4.22 (t, J=6 Hz, 4H, OCH₂ 's); 6.42, 6.53, 7.54, 7.71 (sets ofd's, aromatic)

IR(CHCl₃): 1625, 1675, 1730 cm⁻¹

Analysis. Calcd. for C₃₁ H₄₀ O₈ : C, 68.87; H, 7.46. Found: C, 69.12; H.7.44. ##STR9##

EXAMPLE 73-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoicacid

A solution of 0.5 g (9.5 mmole) of lithium hydroxide in 10 ml of waterwas added to a solution of 2.2 g (3.9 mmole) of the title compound ofExample 6 in 25 ml of tetrahydrofuran and 20 ml of methanol. After thereaction mixture was stirred for 3 hours at room temperature, thesolvent was evaporated and water was added to the residue. Afterextracting with a small amount of diethyl ether, the aqueous layer wasacidified with dilute hydrochloric acid and allowed to stand in the coldovernight. The solid was filtered, washed with water and recrystallizedfrom ethyl acetate/hexane to yield 1.83 g of the title compound, mp.80°-83°. Structure assignment was confirmed by nmr and infrared spectraand by elemental analysis. nmr (CDCl₃) loss of ester CH₃ (compareExample 6)

IR(KBr): 1625, 1675, 1710, 1730 cm⁻¹

Analysis. Calcd. for C₃₁ H₃₈ O₈ ·H₂ O: C, 66.16; H, 7.40. Found: C,66.15; H, 7.44. ##STR10##

EXAMPLE 81-[3-(7-(3-bromoproxy)-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2yl)-1-oxopropyl]pyrrolidine

The title compound, mp 103°-104°, was prepared by the method of Example6 using the amide pyrrolidone product of Example 2 and1,3-dibromopropane as starting materials. Structure assignment wasconfirmed by nmr and infrared spectra and by elemental analysis.

IR(CHCl₃) 1625, 1675 cm⁻¹

Analysis. Calcd. for C₂₃ H₃₂ BrNO₄ : C, 59.23; H, 6.92; N, 3.00. Found:C, 59.44; H, 6.96; N, 2.84. ##STR11##

EXAMPLE 91-[3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]-1-oxopropyl]pyrrolidine

The title compound, mp 93°-94.5°, was prepared by the method of Example6 using the title compound of Example 8 and2,4-dihydroxy-3-propylacetophenone as starting materials. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

IR(CHCl₃) 1625, 1675 cm⁻¹

Analysis. Calcd. for C₃₄ H₄₅ NO₇ : C, 70.44; H, 7.82; N, 2.42. Found: C,70.32; H, 7.78; N, 2.35. ##STR12##

EXAMPLE 10 methyl 3-(3,4-dihydro-7-hydroxy-2-methyl-8-propyl-2H-1-benzopyran-2-yl)propanoate

A solution of 4.1 g (13.4 mmole) of ester product of Example 4 in 100 mlof acetic acid and 50 ml of methanol was hydrogenated for 21 hours at 4psi and room temperature using palladium on carbon as catalyst. Thecatalyst was filtered and the filtrate was evaporated to dryness.Chromatography of the residue on silica gel using 20% ethylacetate/hexane as eluent gave 1.8 g of the title compound as an oil.Structure assignment was confirmed by nmr and infrared spectra.

nmr (CKCl₃): δ(ppm) 0.94 (t, J=7 Hz, 3H, propyl CH₃); 1.23 (s, 3H,2-methyl protons); 3.67 (s, 3H, ester CH₃); 6.28 (d, J=8 Hz, 1H,aromatic); 6.71 (d, J=8 Hz, 1H, aromatic)

IR(CHCl₃): 1730 cm⁻¹ ##STR13##

EXAMPLE 11 methyl3-[7-(3-bromopropoxy)3,4-dihydro-2-methyl-8-propyl-2H-1-benzopyran-2-yl]propanoate

To a solution of 1.7 g (5.51 mmole) of the title compound from Example10, 1.1 ml (11 mmoles) of 1,3-dibromopropane and 1.9 g (11 mmole) oftetrabutylammonium hydrogen sulfate in 12 ml of methylene chloride wasadded 5.5 ml of 2M sodium hydroxide solution. The reaction mixture washeated to reflux for 15 minutes and cooled. The organic layer wasseparated, washed with brine, dried over sodium sulfate, filtered, andconcentrated to dryness. Chromatography of the residue on silica gelusing 10% ethyl acetate/hexane as eluent gave 1.8 g of the titlecompound as an oil. Structure assignment was confirmed by nmr andinfrared spectra.

nmr (CDCl₃) addition of CH₂ Br signal at δ(ppm) 4.02 (t, J=6 Hz)(compare Example 10)

IR(CHCl₃): 1735 cm⁻¹ ##STR14##

EXAMPLE 12 methyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-8-propyl-2H-1-benzopyran-2-yl]propanoate

The title compound mp. 53°-55°, was prepared by the method of Example 6using the product of Example 11 and 2,4-dihydroxy-3-propylacetophenoneas starting materials. Structure assignment was confirmed by nmr andinfrared spectra and by elemental analysis.

IR(CHCl₃): 1625, 1730 cm⁻¹

Analysis. Calcd. for C₃₁ H₄₂ O₇ : C, 70.70; H, 8.04. Found: C, 70.59; H.8.10. ##STR15##

EXAMPLE 133-[7-[3-(4-acetyl-3-hydroxy-2-propyl-phenoxy)propoxy]-3,4-dihydro-2-methyl-8-propyl-2H-1-benzopyran-2-yl]propanoicacid

The title compound was prepared by the method of Example 7 using theproduct of Example 12 as starting material, except that the acidifiedaqueous layer was extracted with ethyl acetate. The organic layer wasthen washed with water and brine, dried over MgSO₄, filtered, andevaporated to dryness to afford the title compound as an oil. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

IR(KBr): 1620, 1705, 1735 cm⁻¹

Analysis. Calcd. for C₃₀ H₄₀ O₇ : C, 70.29; H, 7.87. Found: C, 69.93; H.7.77. ##STR16##

EXAMPLE 143-(2-carboxy-3,4-dihydro-7-hydroxy-4-oxo-8-propyl-2H-1-benzopyran-2-yl)propanoicacid

The title compound was prepared by the method of Example 1 usingα-ketoglutaric acid as starting material. The crude product was usedwithout further purification. α-ketoglutaric acid can be replaced withhomolegues, for instance, 4-ketopinslic acid to produce homologous ofthe title compound. ##STR17##

EXAMPLE 15 methyl 3-(3,4-dihydro-7-hydroxy-2-methoxycarbonyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl) propanoate

To a solution of 13 g of the crude product of Example 14 in 250 ml ofmethanol and 25 ml of trimethylorthoformate was added 5 ml of sulfuricacid. The reaction mixture was stirred for 12 hours at room temperature,poured onto an ice/water mixture, and extracted with ethyl acetate. Theorganic layer was washed successively with water, 5% sodium bicarbonatesolution, water and brine, dried over MgSO₄, filtered, and evaporated todryness. Chromatography of the residue on silica gel using 13% ethylacetate/hexane as eluent gave 6.1 g of the title compound. Structureassignment was confirmed by nmr and infrared spectra.

nmr (CDCl₃): δ(ppm) 0.99 (t, J=6 Hz, 3H, propyl CH₃); 3.64, 3.71 (pairs, 6H, ester CH₃ 's); 6.45, 7.56 (pair d's, aromatic)

IR(CHCl₃): 1685, 1740 cm⁻¹ ##STR18##

EXAMPLE 16 methyl 3-[7-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methoxycarbonyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoate

The title compound was prepared by the method of Example 2 using theproduct of Example 11 as starting material. Structure assignment wasconfirmed by nmr and infrared spectra and by elemental analysissubstituting appropriate compounds homologs where 1 is 1 or 2 may bemade.

nmr (CDCl₃): δ(ppm) 0.88, 0.93 (pair t, 6H, propyl CH₃ 's); 2.56, (s,3H, acetyl CH₃); 3.61, 3.68 (pair s, 6H, ester CH₃ 's) 4.21 (t, J=7 Hz,4H, OCH₂ 's); 6.39, 6.55, 7.53, 7.66 (sets of d's, aromatic)

IR(CHCl₃): 1630, 1685, 1740 cm⁻¹

Analysis. Calcd. for C₃₂ H₄₀ O₁₀ : C, 65.74; H, 6.90. Found: C, 65.89;H. 6.87. ##STR19##

EXAMPLE 17 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-2-carboxy-3,4-dihydro-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoicacid

The title compound, mp. 76°-79°, was prepared by the method of Example 7using the product of Example 16 as starting material, except that tenequivalents of lithium hydroxide were used. The acidified aqueous layerwas extracted into ethyl acetate, which was then washed with water andbrine, dried over MgSO₄, filtered, and evaporated to dryness to give thetitle compound. Structure assignment was confirmed by nmr and infraredspectra and by elemental analysis.

nmr (CDCl₃): loss of ester CH₃ s (compare Example 16)

IR(KBr): 1620, 1680, 1710-1740 cm⁻¹

Analysis. Calcd. for C₃₀ H₃₆ O₁₀.H₂ O: C, 62.71; H, 6.67. Found: C,62.85; H. 6.64. ##STR20##

EXAMPLE 183-(3,4-dihydro-7-hydroxy-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)propanamide

To a solution of the title product of Example 3, (1.0 g, 3.4 mmole) in50 ml of dry tetrahydrofuran cooled to 0° was added 2.1 g (10.2 mmole)of phosphorus pentachloride. After the mixture was stirred for 30minutes, approximately 2 ml of liquid ammonia was added, and thesolution was warmed to room temperature and stirred for an additional 30minutes. The solvent was evaporated and the residue was dissolved inethyl acetate. The organic layer was washed successively with saturatedsodium bicarbonate solution, water, and brine, dried over MgSO₄,filtered, and concentrated to dryness. The crude product, mp. 108°-115°,was not purified further. Structure assignment was supported by nmr andinfrared spectra.

IR(KBr): 1680 cm⁻¹ ##STR21##

EXAMPLE 19 3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanamide

The title compound, mp 77°-79°, was prepared by the method of Example 6using the amide product of Example 18 as starting material, except thatafter stirring at room temperature for 16 hours the reaction mixture wasfurther heated at 50° for three hours. Structure assignment wasconfirmed by nmr and infrared spectra and by elemental analysis.

IR(KBr): 1630, 1675 cm⁻¹

Analysis. Calcd. for C₃₀ H₃₉ O₇ : C, 68.55; H, 7.48; N, 2.66. Found: C,68.62; H. 7.81; N, 2.49. ##STR22##

EXAMPLE 203-(3,4-dihydro-7-hydroxy-N,N,2-trimethyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)propanamide

To a solution of the title product of Example 3, (1.0 g, 3.4 mmole) in40 ml of dry dimethylformamide cooled to -20° was added 0.37 ml (3.4mmole) of N-methylmorpholine, followed by a solution of 0.45 ml (3.4mmole) of isobutylchloroformate in 3 ml of dimethylformamide. Thereaction miture was stirred at -30° for about twenty minutes, afterwhich gaseous dimethylamine was bubbled through for two minutes. Aftertwenty minutes' stirring, the mixture was allowed to warm to roomtemperature and stirred an additional 30 minutes. The solvent wasevaporated and the residue was dissolved in ethyl acetate, which waswashed successively with saturated sodium bicarbonate solution, water,and brine, then dried over MgSO₄. Filtration and removal of the solventgave 0.84 g of the title compound, mp. 108-110°. Structure assignmentwas confirmed by nmr and infrared spectra.

nmr (CDCl₃): δ(ppm) 0.97(t, J=7 Hz, 3H, propyl CH₃); 1.39, (s, 3H,2-methyl protons); 2.89, 3.06 (pair s, 6H, N(CH₃)₂); 6.55 7.52 (sets ofd's, aromatic)

IR(KBr): 1625, 1985 cm⁻¹ ##STR23##

EXAMPLE 213-[7-[3-(4-acetyl-3-hydroxy-2-propylhenoxy)propoxy]-3,4-dihydro-N,N,2-trimethyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanamide

The title compound, mp. 126°-128°, was prepared by the method of Example6 using the amide product of Example 20 as starting material. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

nmr (CDCl₃): additional signals for aryloxypropoxy protons (compareExample 20)

IR(KBr): 1635, 1685 cm⁻¹

Analysis. Calcd. for C₃₂ H₄₃ NO₇ : C, 69.41; H, 7.83; N, 2.63. Found: C,69.06; H. 7.87; N, 2.51. ##STR24##

EXAMPLE 223-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoicacid, monopotassium salt

A solution of 0.13 g (1.9 mmole) of 85% potassium hydroxide in 25 ml ofmethanol was added to a solution of 1.0 g (1.8 mmole) of the titlecompound of Example 7 in 25 ml of methanol. The solution was neutralizedwith a sulfonic acid-type cation exchange resin, filtered, andevaporated to dryness. The residue was triturated with diethyl ether togive 0.7 g of the title compound. Structure assignment was confirmed byelemental analysis.

Analysis. Calcd. for C₃₀ H₃₇ O₈ K.3/2H₂ O: C, 60.89; H, 6.81; K, 6.61.Found: C, 61.08; H. 6.71; K, 6.69. ##STR25##

EXAMPLE 233-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoicacid, tris(hydroxyethyl)ammonium salt

To a solution of 0.8 g (1.5 mmole) of the title compound of Example 7 in25 ml of methanol was added 0.2 ml (1.5 mmole) of triethanolamine. Thesolvent was evaporated and the residue was triturated with ether to givea solid. Recrystallization from ether/hexane gave 0.6 g of the titlecompound, mp. 84°-85°. Structure assignment was confirmed by nmr andinfrared spectra and by elemental analysis.

IR(CHCl₃): 1620, 1670, 1700, 1740 cm⁻¹

Analysis. Calcd. for C₃₆ H₅₃ O₁₁ N: C, 63.98; H, 7.91; N, 2.07. Found:C, 63.86; H. 8.01; N, 1.98. ##STR26##

EXAMPLE 243-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoicacid, 5-amino-5-carboxypentanaminium salt

The title compound, mp. 125°-127°, was prepared by the method of Example23 using 0.98 g (1.8 mmole) of the title compound of Example 7 and 0.24g (1.6 mmole) of DL-lysine as starting materials. Structure assignmentwas confirmed by nmr and infrared spectra and by elemental analysis.

IR(KBr): 1635, 1685 cm⁻¹

Analysis. Calcd. for C₃₆ H₅₂ O₁₀.1/2H₂ O: C, 66.42; H, 7.84; N, 4.11.Found: C, 63.43; H, 7.79; N, 4.09. ##STR27##

EXAMPLE 25 Methyl4-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]butanoate

The title compound was prepared by the methods of Examples 1 and 6 usingmethyl 5-oxohexanoate as starting material. Structure assignment wasconfirmed by nmr and infrared spectra and by elemental analysis.

IR(CHCl₃): 1625, 1675, 1730 cm⁻¹

Analysis. Calcd. for C₃₂ H₄₂ O₈ : C, 69.29; H, 7.63. Found: C, 68.80; H,7.72. ##STR28##

EXAMPLE 264-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]butanoicacid

The title compound, mp. 106°-108°, was prepared by the method of Example7 using the title compound of Example 25 as starting material. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

IR(CHCl₃): 1625, 1675, 1710, 1750 cm⁻¹

Analysis. Calcd. for C₃₁ H₄₀ O₈ : C, 68.87; H, 7.46. Found: C, 68.68; H,7.79. ##STR29##

EXAMPLE 27 ethyl3-(3,4-dihydro-7-hydroxy-8-propyl-2H-1-benzopyran-2-yl)propanoate

A solution of 2.0 g (5.1 mmole) ethyl3-(4-oxo-7-phenylmethoxy-8-propyl-4H-1-benzopyran-2-yl)-2-propenoate in40 ml of acetic acid was hydrogenated at 50 psi and 70° over 5%palladium on carbon catalyst. The catalyst was removed by filtration andthe filtrate was evaporated to dryness to give 1.3 g of the titlecompound as an oil. Structure assignment was supported by nmr andinfrared spectra.

nmr (CDCl₃): δ(ppm) 0.95 (t, J=7 Hz, 3H, propyl CH₃); 1.27 (t, J=7 Hz,3H, ester CH₃); 3.9 (m, lH, 2-proton); 4.13 (q, J=7 Hz, 2H, ester CH₂);6.29, 6.69 (pair d, aromatic)

IR(CHCl₃): 1725 cm⁻¹ ##STR30##

EXAMPLE 28 ethyl3-[7-(3-bromopropoxy)-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]propanoate

The title compound was prepared by the method of Example 11 using theproduct of Example 27 as starting material. Structure assignment wassupported by nmr and infrared spectra.

nmr (CDCl₃): additional signals include δ(ppm) 3.59 (t, J=7 Hz, 2H, CH₂Br) (compare Example 27)

IR(CHCl₃): 1725 cm⁻¹ ##STR31##

EXAMPLE 29 ethyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]propanoate

The title compound, mp. 68°-70°, was prepared by the method of Example 6using the product of Example 28 as starting material. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

nmr (CDCl₃): δ(ppm) 0.89 (t, J=7 Hz, 6H, propyl CH₃ 's); 1.25 (t, J=7Hz, 3H, ester CH₃); 2.27 (t, J=6H, 2H, CH₂ CH₂, CH₂); 2.54 (s, 3H,acetyl CH₃); 3.9 (m, 1H, 2-proton); 6.39, 6.42, 6.78, 7.54 (sets of d's,aromatic)

IR(CHCl₃) 1625, 1725 cm⁻¹

Analysis. Calcd. for C₃₁ H₄₂ O₇ : C, 70.70; H, 8.04. Found: C, 70.57; H,8.09. ##STR32##

EXAMPLE 303-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]propanoicacid

The title compound, mp. 109°-110°, was prepared by the method of Example7 using the product of Example 29 as starting material. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

nmr (CDCl₃): loss of ester protons (compare Example 29)

IR(KBr): 1635, 1705 cm⁻¹

Analysis. Calcd. for C₂₉ H₃₈ O₇ : C, 69.86; H, 7.68. Found: C, 69.83; H,7.68. ##STR33##

EXAMPLE 31 ethyl3-[3,4-dihydro-7-(2-oxiranylmethoxy)-8-propyl-2H-1-benzopyran-2-yl]propanoate

The title compound was prepared by the method of Example 11 using 3.0 g(10.3 mmole) of the product of Example 27 and 1.3 ml (15 mmole) ofepibromohydrin as starting materials. Structure assignment was supportedby nmr and infrared spectra.

IR(CHCl₃) 1725 cm⁻¹ ##STR34##

EXAMPLE 32 ethyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]propanoate

To a solution of 2.9 g (8.3 mmole) of the title compound of Example 31and 2.4 g (12.5 mmole) of 2,4-dihydroxy-3-propylacetophenone in 30 ml ofdry dimethylformamide was added two drops of Triton B. The reactionmixture was heated at 110°-120° for 48 hours, then cooled and evaporatedto dryness. Chromatography of the crude material on silica gel using 20%acetone/hexane as eluent gave 1.6 g of product as an oil. Structureassignment was supported by nmr and infrared spectra.

nmr (CDCl₃) δ(ppm) 0.91, 0.93 (pair t, 6H, propyl CH₃ 's); 1.25 (t, J=7Hz, 3H, ester CH₃); 2.56 (s, 3 Hz, acetyl CH₃); 3.90, (m, 1H, CHOH);4.12 (d, J=7 Hz, 4H, OCH₂ 's); 6.40, 6.43, 6.80, 7.56 (sets of d's,aromatic)

IR(CHCl₃) 1625, 1725 cm⁻¹ ##STR35##

EXAMPLE 333-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]propanoicacid

The title compound was prepared by the method of Example 7 using theester product of Example 32 as starting material. Structure assignmentwas confirmed by nmr and infrared spectra and by elemental analysis.

nmr (CDCl₃): loss of ester protons (compare Example 32)

IR(CHCl₃): 1625, 1705 cm⁻¹

Analysis. Calcd. for C₂₉ H₃₈ O₈ : C, 67.68; H, 7.44. Found: C, 67.03; H,7.39. ##STR36##

EXAMPLE 34 methyl 7-hydroxy-4-oxo-8-propyl-4H-1-benzopyran-2-oate

To a solution of 99.7 g (0.513 mole) of2,4-dihydroxy-3-propylacetophenone and 72.7 g (0.77 mole) of dimethyloxalate in 1 liter of dry dimethylformamide was added in portions 97 g(1.8 mmole) of sodium methoxide. After stirring for 4 hours, 1.8 l ofacetic acid was added and stirring was continued for 4 days. Thereaction mixture was heated in a steam bath for four hours andevaporated to dryness. Water was added to the residue and the mixturewas heated to boiling. A solid was filtered off and recrystallized fromethanol to give 89.8 g of the title compound, mp. 222°-224°. Structureassignment was supported by nmr and infrared spectra.

IR(KBr): 1650, 1745 cm⁻¹ ##STR37##

EXAMPLE 35 methyl 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-oxo-8-propyl-4H-1-benzopyran-2-oate

The title compound was prepared by the method of Example 6 using theproduct of Example 34 as starting material. Structure assignment wasconfirmed by nmr and infrared spectra.

nmr (CDCl₃): δ(ppm) 0.89, 0.93 (pair t, 6H, propyl CH₃ 's); 2.55 (s, 3H,acetyl CH₃); 2.62, 2.88 (pair t, 4, OCH₂ 's); 6.98 (s, 1H, C=CH); 6.42,7.00, 7.54, 8.00 (sets of d's, aromatic)

IR(CHCl₃) 1650, 1745 cm⁻¹ ##STR38##

EXAMPLE 36 methyl 7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-oate

The title compound was prepared by the method of Example 27 using 30.7 g(61.9 mmole) of the product of Example 35 as starting material.Structure assignment was supported by nmr and infrared spectra.

nmr (CDCl₃): loss of alkenyl proton, addition of 2-proton at δ(ppm) 4.41(t, J=5 Hz) (compare Example 35)

IR(CHCl₃): 1610, 1620, 1730, 1750 cm⁻¹ ##STR39##

EXAMPLE 37 7-[3-(3-hydroxy-4-(1-hydroxyethyl)-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-ylmethanol

A solution of 2.8 g (0.13 mole) of lithium borohydride in 500 ml oftetrahydrofuran was added to a solution of 25.0 g (51.6 mmole) of thetitle compound of Example 36 in 200 ml of tetrahydrofuran. The reactionmixture was stirred at room temperature for two hours and heated toreflux for one hour. After cooling the mixture, the excess borohydridereagent was destroyed by the addition of water and then a small amountof dilute hydrochloric acid. The reaction mixture was diluted with ethylacetate and washed successively with sodium bicarbonate solution, waterand brine, dried over MgSO₄, filtered, and evaporated to dryness.Chromatography of the residue on silica gel using 40% ethylacetate/hexane as eluent gave 16.5 g of the title compound as an oil.Structure assignment was supported by nmr and infrared spectra.

nmr (CDCl₃): loss of ester CH₃, change in acetyl CH₃ to δ(ppm) 1.55 (d,J=7 Hz); additional signal at 4.96 (q, J=6 Hz, IH, methyl-CHO-) (compareExample 36)

IR(CHCl₃) no carbonyl band between 1600 and 1800 cm⁻¹ ##STR40##

EXAMPLE 387-[3-(4-(1-hydroxyethyl)-3-(phenylmethoxy)-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-ylmethanol

The title compound was prepared by the general method of Example 11using the product of Example 37 and benzyl chloride as startingmaterials. Structure assignment was supported by nmr and infraredspectra.

IR(CHCl₃): no carbonyl band between 1600 and 1800 cm⁻¹

nmr (CDCl₃): additional aromatic protons (compare Example 37) ##STR41##

EXAMPLE 397-[3-(4-acetyl-3-(phenylmethoxy)-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-ylmethanol

To a solution of 8.9 g (16.2 mmole) of the title compound of Example 38in 150 ml of methylene choride was added 18 g (162 mmole) of manganesedioxide. The reaction mixture was stirred at room temperature for 12hours and filtered. Removal of the solvent gave 6.9 g of the titlecompound, mp. 83°-85°. Structure assignment was supported by nmr andinfrared spectra.

IR(CHCl₃): 1665 cm⁻¹

nmr (CDCl₃): reappearance of acetyl CH₃ at δ(ppm) 2.55 (s, 3H) (compareExamples 36, 37, 38) ##STR42##

EXAMPLE 40 7-[3-(4-acetyl-3-(phenylmethoxy)-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-carboxaldehyde

A solution of 1.2 ml (13.3 mmole) of oxalyl chloride in 30 ml ofmethylene chloride was cooled to -70°, and a solution of 1.9 ml (26.6mmole) of dimethylsulfoxide in 9 ml of methylene chloride was added. Themixture was stirred for 5 minutes and a solution of 6.6 g (12.1 mmole)of the title compound of Example 39 in 20 ml of methylene chloride wasadded. After stirring an additional 15 minutes, 8.5 ml (60.5 mmole) oftriethylamine was added, and the mixture was stirred at -70° for 5minutes and allowed to warm to room temperature. Water was added and thelayers were separated. The organic layer was washed successively withdilute hydrochloric acid, 5% sodium bicarbonate solution, water andbrine, dried over MgSO₄, and filtered. Removal of the solvent gave 6.44g of the title compound as a yellow oil. Structure assignment wassupported by nmr and infrared spectra.

nmr (CDCl₃): δ(ppm) 9.76 (s, 1H, CHO)

IR(CHCl₃): 1665, 1735 cm⁻¹ ##STR43##

EXAMPLE 413-[7-[3-(4-acetyl-3-(phenylmethoxy)-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]-2(Eand Z)-propenenitrile

To a solution of 6.35 (11.7 mmole) of the title compound of Example 40in 150 ml of benzene was added 4.04 g (13.5 mmole) ofcyanomethylenetriphenylphosphorane. The reaction mixture was stirred for12 hours at room temperature and evaporated to dryness. Chromatographyof the residue on silica gel using 20% ethyl acetate/hexane as eluentgave 1.3 g of the cis isomer, 0.8 g of the trans isomer and 1.1 g of a53:47 cis/trans mixture. Structure assignment was supported by nmr andinfrared spectra.

nmr (CDCl₃) (cis isomer): δ(ppm) 5.44 (dd, J₁ =11 Hz, J₂ =1.5 Hz, 1H,CHCN) (trans isomer): δ(ppm) 5.69 (dd, J₁ =16 Hz, J₂ =3 Hz 1H, CHCN);6.77 (dd, J₁ =16 Hz, J₃ =4 Hz, 1H, HC=C-CN)

IR(CHCl₃) (cis isomer): 1665, 2210 cm⁻¹ (trans isomer): 1665, 2230 cm⁻¹##STR44##

EXAMPLE 423-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]-2(Z)-propenenitrile

To 1.4 g (2.4 mmole) of the cis isomer product of Example 41 in 70 ml ofmethylene chloride cooled to -78°, was added 9.7 ml (9.6 mmole) of a 1Msolution of boron trichloride in methylene chloride. After addition wascomplete, the reaction was poured onto an ice/water mixture andadditional methylene chloride was added. The organic layer was washedwith water and brine, dried over MgSO₄, and filtered. Removal of thesolvent gave 1.13 g of the title compound as an oil. Structureassignment was supported by nmr and infrared spectra.

nmr (CDCl₃): δ(ppm) 5.46 (dd, J₁ =11 Hz, 1H, CHCN); 6.67 (dd, J₁ =11 Hz,J₃ =3.5 Hz, 1H, HC=C-CN); loss of ester protons (compare Example 41)

IR(CHCl₃): 1625, 2230 cm⁻¹ ##STR45##

EXAMPLE 433-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]propanenitrile

A solution of 1.6 g (3.4 mmole) of the title compound of Example 42 in27 ml of ethyl acetate and 3 ml of acetic acid was hydrogenated atatmospheric pressure and room temperature using 10% palladium on carboncatalyst. The catalyst was removed by filtration and the filtrate wasevaporated to dryness. Chromatography of the residue on silica gel using20% ethyl acetate/hexane as eluent gave 1.3 g of the title compound, mp.89°-89.5°. Structure assignment was confirmed by nmr and infraredspectra and by elemental analysis.

nmr (CDCl₃): loss of alkenyl protons (compare Example 41)

IR(CHCl₃): 1625, 2250, cm⁻¹

Analysis. Calcd. for C₂₉ H₃₇ O₅ N: C, 72.62; H, 7.78; N, 2.92. Found: C,72.92; H, 7.79; N, 2.85. ##STR46##

EXAMPLE 44 methyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoate

A solution of 1.9 g (3.6 mmole) of methyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-4-oxo-8-propyl-3H-1-benzopyran-2-yl]propanoatein 20 ml of ethanol and 20 ml of tetrahydrofuran was hydrogenated atroom temperature and 2 psi using Raney nickel catalyst. The reactionmixture was filtered and evaporated to dryness. Chromatography of thecrude material on silica gel using 4% acetone/toluene as eluent afforded0.9 g of the title compound, mp. 101°-101.5°. Structure assignment wasconfirmed by nmr and infrared spectra and by elemental analysis.

IR(CHCl₃): 1625, 1675, 1730 cm⁻¹

Analysis. Calcd. for C₃₀ H₃₈ O₈ : C, 68.42; H, 7.27. Found: C, 68.30; H,7.22. ##STR47##

EXAMPLE 45 methyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-4-hydroxy-8-propyl-2H-1-benzopyran-2-yl]propanoate

Other chromatographic fractions of Example 44 afforded 1.0 g of thetitle alcohol, m.p. 125°-125.5°. Structure assignment was confirmed bynmr and infrared spectra and by elemental analysis.

IR(CHCl₃): 1630, 1735 cm⁻¹

Analysis. Calcd. for C₃₀ H₄₀ O₈ : C, 68.16; H, 7.63. Found: C, 68.21; H,7.60. ##STR48##

EXAMPLE 463-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoicacid

The title compound, mp. 149°-150°, was prepared by the method of Example7 using the ketone product of Example 44 as starting material. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

IR(KBr): 1635, 1665, 1725 cm⁻¹

Analysis. Calcd. for C₂₉ H₃₆ O₈ : C, 67.95; H, 7.07. Found: C, 67.73; H,7.05. ##STR49##

EXAMPLE 47 methyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-8-propyl-2H-1-benzopyran-2-yl]propanoate

A solution of 0.2 g (2.4 mmole) of methanesulfonyl chloride in 5 ml ofmethylene chloride was added dropwise to a cooled (-20°) solution of 1.0g (2.0 mmole) of the hydroxy product of Example 45 and 0.7 ml (5 mmole)of triethylamine in 20 ml of methylene chloride. The reaction mixturewas cooled at -5° for 16 hours, then poured onto ice and extracted withdiethyl ether. The organic layer was washed successively with 2Mhydrochloric acid, 10% sodium bicarbonate solution, and water, thendried over MgSO₄ and filtered. Removal of the solvent gave 0.6 g of thetitle compound as an oil. Structure assignment was confirmed by nmr andinfrared spectra.

nmr (CDCl₃): δ(ppm) 3.64 (s, 3H, ester CH₃); 4.8 (m, 1H, 2-proton); 5.5(dd, J₁ =10 Hz, 1H, 3-proton); 6.75 (dd, J₁ =10 Hz, 1H, 4-proton)

IR(CHCl₃): 1605, 1625, 1745 cm⁻¹ ##STR50##

EXAMPLE 483-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-8-propyl-2H-1-benzopyran-2-yl]propanoicacid

The title compound, mp. 60°-62°, was prepared by the method of Example 7using the product of Example 47 as starting material. Structureassignment was confirmed by nmr and infrared spectra and by elementalanalysis.

nmr (CDCl₃): δ(ppm) 5.58 (dd, J₁ =10 Hz, J₂ =3 Hz, 1H, 3-proton); 6.37(dd, J₁ =10 Hz, J₃ =1.5 Hz, 1H, 4-proton); loss of ester CH₃.

IR(KBr): 1605, 1625, 1725, 1730 cm⁻¹

Analysis. Calcd. for C₂₉ H₃₆ O₇ : C, 70.14; H, 7.31. Found: C, 69.94; H,7.11. ##STR51##

EXAMPLE 493,4-dihydro-7-hydroxy-2-methyl-4-oxo-8-propyl-2H-2-benzopyran-2-carboxaldehyde

A solution of 30.0 g of 2,4-dihydroxy-3-propylacetophenone in 125 ml oftoluene containing 15.5 ml of pyrrolidine was heated at reflux using aDean-Stark trap to remove water. After 29.2 ml of pyruvaldehyde dimethylacetal was added to the cooled (ca. 0°) solution, the mixture was heatedto reflux as additional water was removed. After five hours anadditional 5.2 ml of pyrrolidine was added and the mixture was refluxeda further 18 hours. The reaction mixture was cooled, concentrated, andtaken up in ethyl acetate. The resultant solution was washedsequentially with water, 1N hydrochloric acid, and brine, dried overmagnesium sulfate, filtered, and concentrated to dryness. The residuewas dissolved in ethyl acetate/hexane, filtered through silica gel, andconcentrated to an oil which was purified by column chromatography onsilica gel. The intermediate acetal derivative of the title compound wascollected as a yellow solid (13.7 g) which was used without furtherpurification to prepare the title compound. (An analytically puresample, m.p. 146°-148°, was recrystallized from ethyl acetate/hexane.) Asolution of 2.0 g of the intermediate acetal in 20 ml of acetic acidcontaining 10 ml of 10% sulfuric acid was heated at 80° for three hours.The mixture was taken up in ethyl acetate, washed with water, aqueoussodium bicarbonate, and brine, then dried with magnesium sulfate,filtered, and concentrated. The title compound, isolated as 1.7 g of anoil, was used in subsequent reactions without further purification.Structure assignment was supported by nmr and infrared spectra.

nmr (CDCl₃): δ(ppm) 0.99, 1.55, 2.70 (t, m, t, 7H, propyl protons); 1.53(s, 3H, methyl); 2.88 (g, 2H, ring CH₂); 6.52, 7.62 (pair d, aromatic);9.60 (s, 1H, CHO)

IR (CHCl₃): 1740, 1675 cm⁻¹ ##STR52##

EXAMPLE 502R-(3,4S-dimethyl-5R-phenyl-2S-oxazolidinyl)-3,4-dihydro-7-hydroxy-2-methyl-8-propyl-2H-1-benzopyran-4-one

A solution of 20.0 g of the title compound of Example 49 and excess1-ephedrine in 150 ml of benzene was heated at reflux using a Dean-Starktrap to remove water. After four hours at reflux the solution wasfiltered through silica gel, washing with 50% by volume ethylacetate/hexane, and then concentrated to dryness in vacuo. Columnchromatography on silica gel using ethyl acetate/hexane, after recyclingto obtain only the least polar component, afforded 1.1 g of the titlecompound, m.p. 196°-197°. Structure determination was confirmed by X-raycrystallography.

[α]_(D) -2.1° (1.029% in acetone) ##STR53##

EXAMPLE 512S-(3,4R-dimethyl-5S-phenyl-2R-oxazolidinyl)-3,4-dihydro-7-hydroxy-2-methyl-8-propyl-2H-1-benzopyran-4-one

The title compound (4.85 g), m.p. 196°-198°, was prepared by the methodof Example 50 using 17 g of the title compound of Example 49 and excessd-ephedrine. The optical rotation of the title compound was opposite insign to that for the title product of Example 50.

[α]_(D) +1.6° (1.014% in acetone) ##STR54##

EXAMPLE 523,4-dihydro-7-hydroxy-2-methyl-4-oxo-8propyl-2H-1-benzopyran-2R-carboxaldehyde

The title compound of Example 50 (4.1 g) was dissolved in 150 ml ofmethanol to which was then added 12 g of Dowex-50 (H⁺ form) and 50 ml ofwater. After 2.5 hours at 50° the mixture was filtered and the filtrateconcentrated in vacuo to give 1.2 g of the title compound. A second cropof the product was obtained by suspending the recovered exchange resinin 100 ml of 90% aqueous methanol, adding an additional 4 g of Dowex-50,heating at 60° for three hours, filtering, and concentrating to dryness.A total of 2.4 g of aldehyde product was obtained. The (R)-aldehyde wasused for subsequent reactions without further purification. ##STR55##

EXAMPLE 533,4-dihydro-7-hydroxy-2-methyl4-oxo-8-propyl-2H-1-benzopyran-2S-carboxaldehyde

The title compound (3.05 g) was prepared by the method of Example 52using 5.0 g of the title compound of Example 51. The (S)-aldehyde wasused for subsequent reactions without further purification. ##STR56##

EXAMPLE 54 ethyl3-(3,4-dihydro-7-hydroxy2R-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(Z)-propenoate

A solution of 1.2 g of the (R)-aldehyde product of Example 52 and 1.8 gof (carbethoxymethylene)triphenylphosphorane was allowed to stand forabout seven hours. The solution was filtered through silica gel and thefiltrate concentrated to dryness. The residue was then chromatographedon silica gel using 18% ethyl acetate/hexane as eluent. Earlychromatographic fractions afforded the title compound (i.e., the cisisomer), m.p. 104°-106° C. ##STR57##

EXAMPLE 55 ethyl3-(3,4-dihydro-7-hydroxy-2R-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(E)-propenoate

Later chromatographic fractions of Example 54 afforded the trans isomer,m.p. 111.5°-112.5°. Structure assignment was supported by nmr spectra,optical rotation, and elemental analysis.

nmr (CDCl₃): alkenyl protons at δ(ppm) 6.00 (d, J=16 Hz), 6.93 (d, J=16Hz)

[α]_(D) +129.0° (0.903% in CHCl₃)

Analysis. Calcd. for C₁₈ H₂₂ O₅ ·1/2H₂ O: C, 66.96; H, 7.02. Found: C,67.08; H, 6.95. ##STR58##

EXAMPLE 56 ethyl3-(3,4-dihydro-7-hydroxy-2S-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(Z)-propenoate

The title compound (i.e., the cis isomer), m.p. 109°-110°, was preparedby the method of Example 54 using 3.05 g of the (S)-aldehyde product ofExample 53 and 4.7 g of the phosphorane reagent. Structure assignmentwas supported by optical rotation and elemental analysis.

[α]_(D) -185.8° (0.771% in CHCl₃) ##STR59##

EXAMPLE 57 ethyl3-(3,4-dihydro-7-hydroxy-2S-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(E)-propenoate

Later chromatographic fractions of Example 56 afforded the trans isomer,m.p. 110.5°-111.5°. Structure assignment was supported by opticalrotation, and elemental analysis.

[α]_(D) -125.7° (1.015% in CHCl₃)

Analysis. Calcd. for C₁₈ H₂₂ O₅ : C, 67.91; H, 6.97. Found: C, 67.67; H,6.98. ##STR60##

EXAMPLE 58 ethyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2R-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(E)-propenoate

A mixture of 1.1 g of the title compound of Example 55, 1.0 g of thetitle compound of Example 5, and 0.91 g of powdered potassium carbonatein 30 ml of dimethylformamide was stirred at room temperature overnight.The reaction mixture was diluted with ethyl acetate and filtered, andthe filtrate was washed sequentially with ammonium chloride solution andbrine, filtered and concentrated in vacuo to an oil. Columnchromatography on silica gel using 7% ethyl acetate/toluene afforded 1.2g of the title compound, m.p. 135.5°-136.5°. Structure assignment wassupported by optical rotation and elemental analysis.

[α]_(D) +91.8° (1.000% in CHCl₃)

Analysis. Calcd. for C₃₂ H₄₀ O₈ : C, 69.54; H, 7.30. Found: C, 69.32; H,7.25. ##STR61##

EXAMPLE 59 ethyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2S-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(E)-propenoate

The title compound, m.p. 134°-135°, was prepared by the method ofExample 58 using the title compound of Example 57. Structure assignmentwas supported by optical rotation and elemental analysis.

[α]_(D) -87.3° (1.002% in CHCl₃)

Analysis. Calcd. for C₃₂ H₄₀ O₈ : C, 69.54; H, 7.30. Found: C, 69.37; H,6.96. ##STR62##

EXAMPLE 603-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2R-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(E)-propenoicacid

The title compound, m.p. 179.5°-181°, was prepared from 1.05 g of theester product of Example 58 using the general method of Example 7,except that the initially formed solid was purified by columnchromatography on silica gel (using 85:15:1 toluene/ethyl acetate/aceticacid as eluent), giving 0.67 g of pure solid. Structure assignment wassupported by optical rotation and elemental analysis.

[α]_(D) +93.3° (1.001% in CHCl₃)

Analysis. Calcd. for C₃₀ H₃₆ O₈ : C, 68.68; H, 6.92. Found: C, 68.62; H,6.76. ##STR63##

EXAMPLE 613-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propoxy]-3,4-dihydro-2S-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(E)-propenoicacid

The title compound, m.p. 179°-181°, was prepared by the method ofExample 60 using 1.1 g of the ester product of Example 59. Structureassignment was supported by optical rotation and elemental analysis.

[α]_(D) -90.8° (1.002% in CHCl₃)

Analysis. Calcd. for C₃₀ H₃₆ O₈ : C, 68.68; H, 6.92. Found: C, 68.60; H,6.79. ##STR64##

EXAMPLE 62 ethyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2S-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl)-2(Z)-propenoate

The title compound m.p. 98°-99°, was prepared by the method of Example58 using the title compound of Example 56. Structure assignment wassupported by optical rotation and elemental analysis.

[α]_(D) -118.8° (1.013% in CHCl₃)

Analysis. Calcd. for C₃₂ H₄₀ O₈ : C, 69.54; H, 7.30. Found: C, 69.63; H,7.30. ##STR65##

EXAMPLE 63N-{3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]-propanoyl}-L-prolinemethyl ester

The title compound was prepared by the methods of Examples 20 and 21using L-proline methyl ester in place of dimethylamine. Structureassignment was confirmed by the nmr spectrum and by elemental analysis.

nmr (CDCl₃): δ(ppm) 1.35 (s, 3H, 2-methyl protons); 2.55 (s, 3H, acetylCH₃); 3.71 (s, 3H, ester CH₃); 6.42, 6.55, 7.56, 7.72 (sets of d's,aromatic)

Analysis. Calcd. for C₃₆ H₄₇ NO₉ : C, 67.80: H, 7.43; N, 2.20. Found: C,67.68; H, 7.70; N, 2.15. ##STR66##

EXAMPLE 64N-{3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoyl}-L-proline

The title compound was prepared by the method of Example 7 using thetitle product of Example 63, except that sodium hydroxide was usedinstead of lithium hydroxide. Structure assignment was supported byelemental analysis.

Analysis. Calcd. for C₃₅ H₄₅ NO₉ ·H₂ O: C, 65.55; H, 7.38; N, 2.18.Found: C, 65.76; H, 7.44; N, 1.89. ##STR67##

EXAMPLE 65N-{3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoyl}sarcosineethyl ester

The title compound, m.p. 101°-102°, was prepared by the methods ofExamples 20 and 21 using sarcosine ethyl ester in place ofdimethylamine. Structure assignment was confirmed by the nmr spectrumand by elemental analysis.

nmr (CDCl₃): δ(ppm) 2.15 (s, 3H, N--CH₃); 2.55 (s, 3H, acetyl CH₃); 3.07(s, 2H, N--CH₂ --CO); 6.50 (overlapping d's, aromatic); 7.57, 7.72 (pairof d's, aromatic)

Analysis. Calcd. for C₃₄ H₄₇ NO₉ : C, 67.18; H, 7.57; N, 2.24. Found: C,67.12; H, 7.55; N, 2.19. ##STR68##

EXAMPLE 66N-{3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-4-oxo-8-propyl-2H-1-benzopyran-2-yl]propanoyl}sarcosine

The title compound was prepared by the method of Example 7 using thetitle product of Example 65. Structure assignment was supported byelemental analysis.

Analysis. Calcd. for C₃₃ H₄₃ NO₉ ·1/2H₂ O: C, 65.33; H, 7.31; N, 2.31.Found: C, 65.10; H, 7.40; N, 1.98. ##STR69##

EXAMPLE 67 methyl 7-hydroxy-3,4-dihydro-8-propyl-2H-1-benzopyran-2-oate

The title compound, m.p. 51°-53°, was prepared from the title product ofExample 34 (6.6 g, 25 mmole) using the general method of Example 27,except that chromatographic eluent was 15% ethyl acetate-hexane.Structure assignment was supported by nmr, infrared, and ultravioletspectra and by elemental analysis.

nmr (CDCl₃): δ(ppm) 0.95 (t, 3H, propyl CH₃); 3.77 (s, 3H, ester CH₃);4.75 (t, 1H, 2-proton); 6.33, 6.72 (pair d's, aromatic)

IR (CHCl₃): 1740, 1760 cm⁻¹

UV (methanol): ν_(max) 284 nm (ε1830)

Analysis. Calcd. for C₁₄ H₁₈ O₄ : C, 67.18; H, 7.25. Found: C, 67.10; H,7.42. ##STR70##

EXAMPLE 68 methyl7-phenylmethoxy-3,4-dihydro-8-propyl-2H-1-benzopyran-2-oate

The title compound was prepared as an oil using the general method ofExample 6 from the title product of Example 67 (5.25 g, 21 mmole) andbenzyl bromide. Structure assignment was supported by nmr, infrared, andultraviolet spectra and by elemental analysis. nmr (CDCl₃): additionalsignals for benzyl protons at

δ (ppm) 5.03, 7.38 (compare Example 67)

IR (CHCl₃): 1735, 1755 cm ⁻¹

UV (methanol):λ_(max) 276 nm (ε 1862), 284 nm (ε 1933)

Analysis. Calcd. for C₂₁ H₂₄ O₄ :C, 74.09; H, 7.11. Found: C, 74.11; H,7.06. ##STR71##

EXAMPLE 69 methyl2-(7-phenylmethoxy-3,4-dihydro-2-methoxycarbonyl-8-propyl-2H-1-benzopyran-2-yl)1-cyclopropylcarboxylate

To a solution under argon of 0.77 ml (ca. 5.5 mmole) of diisopropylaminein 300 ml of cold (-10° ), dry tetrahydrofuran was added 2.1 ml of 2.5 Mn-butyl lithium in tetrahydrofuran. After the solution was cooledfurther to -70°, 1.7 g (5 mmole) of the title product of Example 68 in10 ml of dry tetrahydrofuran was slowly added with stirring. After onehour a solution of 0.87 ml (ca. 6.3 mmole) of methyl 4-bromocrotonate in10 ml of tetrahydrofuran was added slowly. The reaction mixture wasallowed to warm to about 0° and then quenched with dilute hydrochloricacid. The mixture was poured into 150ml of diethyl ether, washedsequentially with water, saturated sodium bicarbonate, and brine, andthen dried over magnesium sulfate, filtered, and concentrated in vacuoto an oil. Purification by high performance liquid chromatographyafforded the title compound as an oil which slowly crystallized, m.p.82°-84°. Structure assignment was supported by nmr, infrared, andultraviolet spectra and by elemental analysis.

nmr (CDCl₃) δ(ppm) 0.94 (t, 3H, propyl CH₃); 3.66, 3.68 (pair s's, 6H,ester CH₃ 's); 5.02 (s, 2H, benzyl CH₂); 6.3-7.4 (aromatic)

IR (CHCl₃) 1720 cm⁻¹

UV (methanol): λ_(max) 276 nm (sh; ε1875), 284 nm (ε 1964)

Analysis. Calcd. for C₂₆ H₃₀ O₆ : C, 71.21; H, 6.90. Found: C, 70.41; H,6.88. ##STR72##

EXAMPLE 70 methyl2-(7-hydroxy-3,4-dihydro-2-methoxy-carbonyl-8-propyl-2H-1-benzopyran-2-yl)-1-cyclopropylcarboxylate

The title compound (530 mg) was prepared from 699 mg (1.6 mmole) of thetitle product of Example 69 using the general method of Example 27,except that the hydrogenolysis solvent was ethanol. Structure assignmentwas supported by the nmr spectrum.

nmr (CDCl₃) loss of benzyl signals (compare Example 69) ##STR73##

EXAMPLE 71 methyl2-(7-(3-bromopropoxy-3,4-dihydro-2-methoxycarbonyl-8-propyl-2H-1-benzopyran-2-yl)-1-cyclopropylcarboxylate

A mixture of 658 mg (1.7 mmole) of the title product of Example 70, 5.18g (25.7 mmole) of 1,3-dibromopropane, 112 mg (0.75 mmole) of sodiumiodide, and 480 mg (3.5 mmole) of anhydrous potassium carbonate washeated for three days at reflux in 15 ml of methyl ethyl ketone in thepresent of 3A molecular sieves. After removal of insolubles byfiltration, the mixture was concentrated in vacuo to an oil.Purification by centrifugal thick-layer chromatography afforded 470 mgof the title compound as an oil, which was used in subsequent reactionswithout further purification. ##STR74##

EXAMPLE 72 methyl2-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methoxycarbonyl-8-propyl-2H-1-benzopyran-2-yl]-1-cyclopropylcarboxylate

The title compound (209 mg) was prepared using the general method ofExample 6 from the title product of Example 71 (470 mg, 0.90 mmole) and2,4-dihydroxy-3-propylacetophenone. Structure assignment was supportedby elemental analysis. Analysis. Calcd. for C₃₃ H₄₂ O₉ : C, 68.02; H,7.26. Found: C, 67.44; H, 7.18. ##STR75##

EXAMPLE 732-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-carboxy-8-propyl-2H-1-benzopyran-2-yl]-1-cyclopropylcarboxylicacid

The title compound, m.p. 138°-140°, was prepared from the title productof Example 72 using the method of Example 7, except that purificationwas effected by centrifugal thick-layer chromatography using 73:25:2hexane-ethyl acetate-acetic acid as eluent. The resultant oilcrystallized as the sesquihydrate upon standing. Structure assignmentwas supported by the nmr spectrum and by elemental analysis. nmr(CDCl₃): δ(ppm) 0.88, 0.90 (pair t's, 6H, propyl CH₃ 's); 1.14 (m, 1H,cyclopropyl-CH distal to carbonyl); 2.00 (m, 1H, cyclopropyl-CH-COO-);2.24, (t, 2H, cyclopropyl CH₂); 2.53 (s, 3H, acetyl CH₃); 6.3-7.3(aromatic)

Analysis. Calcd. for C₃₁ H₃₈ O₉.3/2H₂ O: C, 64.01; H, 7.11. Found:C,64.26; H,6.71. ##STR76##

EXAMPLE 74 ethyl4-(7-phenylmethoxy-3,4-dihydro-2-methoxycarbonyl-8-propyl-2H-1-benzopyran-2-yl]-4-oxobutanoate

The title compound, (3.0 g) was prepared by the general method ofExample 69 using N-(3-ethoxycarbonylpropanoyl)imidazole and, as before,the title compound of Example 68 (5.1 g, 15 mmole), except that thereaction was quenched with 0.5 N sodium bisulfate and extracted usingethyl acetate before chromatography. Structure assignment was supportedby nmr, infrared, and ultraviolet spectra and by elemental analysis. nmr(CDCl₃ (ppm) 0.99 (t, 3H, propyl CH₃); 1.23, (t, 3H, ethyl CH₃); 3.71(s, 3H, methyl ester CH₃); 4.10 (q, 2H, ethyl CH₂); 5.01 (s, 2H, benzylCH₂); 6.3-7.4 (aromatic)

IR (CHCl₃): 1725, 1745 cm⁻¹

UV (methanol) λ_(max) 279 nm (sh; ε2027), 284 nm (δ 2085)

Analysis. Calcd. for C₂₇ H₃₂ O₇ : C, 69.21; H, 6.89. Found: C, 69.34; H,6.94. ##STR77##

EXAMPLE 75 ethyl4-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methoxycarbonyl-8-propyl-2H-1-benzopyran-2-yl]-4-oxobutanoate

The title compound (1.6 g) was prepared from the title product ofExample 74 using the methods of Examples 70, 71 (but withoutchromatography), and 72 (except that 3A molecular sieves were added tothe reaction mixture). Purification was effected by high performanceliquid chromatography using 20% ethyl acetate-hexane, followed bycentrifugal thick-layer chromatography using 20% dioxane-hexane.Structure assignment was supported by nmr, infrared, and ultravioletspectra and by elemental analysis.

nmr (CDCl₃):δ(ppm) 0.90, 0.95 (pair t, 6H, propyl CH₃ 's); 1.23, (t, 3H,ethyl CH₃); 2.55 (s, acetyl CH₃); 3.69 (s, 3H, methyl ester CH₃);6.3-7.4 (aromatic)

IR (CHCl₃): 1625, 1730, 1750 cm⁻¹

UV (methanol):δ_(max) 283 nm (ε 17690)

Analysis. Calcd. for C₃₄ H₄₄ O₁₀ : C, 66.65; H, 7.24. Found: C, 66.62 H,7.31. ##STR78##

EXAMPLE 764-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]-4-oxobutanoicacid

The title compound, m.p. 100°-102°, was prepared from 1.1 g (1.8 mmole)of the title product of Example 75 using the method of Example 7, exceptthat the reaction proceeded for four hours and sodium bisulfate was usedto acidify the reaction mixture. The solid (700 mg) obtained byconcentration of the ethyl acetate extracts to dryness was analyticallypure. Structure assignment was supported by nmr, infrared, andultraviolet spectra and by elemental analysis.

nmr (CDCl₃) loss of methyl and ethyl ester protons; addition of 2-protonat δ(ppm) 4.46 (dd, 1H) (compare Example 75)

IR (CHCl₃) 1630, 1715, 1750 cm⁻¹

UV (methanol):δ_(max) 284 nm (ε18600) Analysis. Calcd. for C₃₀ H₃₈ O₈:C, 68.42; H, 7.27. Found: C, 68.12; H, 7.26. ##STR79##

What is claimed is:
 1. A compound of the formulawherein Z is:(a)--(CH₂)_(n) --; or (b) --(CH₂)_(p) --CH═CH--(CH₂)_(q) --; wherein m isan integer of from 2 to 6 inclusive; wherein n is an integer of from 1to 3 inclusive; wherein p is an integer of from zero to 4 inclusive;wherein q is an integer of from zero to 4 inclusive; wherein p+q isequal to or less than 6; wherein Rl₁, R₂ and R₆ are:(a) alkyl of 1 to 6carbon atoms, inclusive, each being the same or different; wherein R₃is(a) hydrogen; or (b) alkyl of 1 to 6 carbon atoms, inclusive; whereinR₄ is: (a) --CO₂ H; (b) --CO₂ R₆ ; (c) --CONR₇ R₈ ; and wherein R₇ andR₈ are:(a) hydrogen; (b) alkyl of 1 to 6 carbon atoms, inclusive; R₇ andR₈ each being the same or different; or (c) taken together with thenitrogen atom to which they are attached form a 5 to 6 member saturatedN-heterocycle optionally substituted by carboxylic acid or methyl esterthereof with the balance of the members being carbon;or thepharmacologically acceptable addition salts thereof.
 2. A compoundaccording to claim 1 wherein R₃ is alkyl.
 3. Methyl3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-8-propyl-2H-1-benzopyran-2-yl]propanoate,a compound according to claim
 2. 4.3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-2-methyl-8-propyl-2H-1-benzopyran-2-yl]-propanoicacid, a compound according to claim
 2. 5. A compound according to claim1 wherein R₃ is --H.
 6. Ethyl3-∂7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]propanoate,a compound according to claim 5.7.3-[7-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2-yl]propanoicacid, a compound according to claim
 5. 8. A compound of the formula##STR80## wherein Z is: (a) --(CH₂)n--; or(b) --(CH₂)p--CH═CH--(CH₂)q--;wherein m is an integer of from 2 to 6 inclusive; wherein n is aninteger of from 1 to 3 inclusive; wherein p is an integer of from zeroto 4 inclusive; wherein q is an integer of from zero to 4 inclusive;wherein p+q is equal to or less than 6; wherein R₁, R₂ and R₆ are: (a)alkyl of 1 to 6 carbon atoms, inclusive, each being the same ordifferent; wherein R₃ is(a) hydrogen; or (b) alkyl of 1 to 6 carbonatoms, inclusive; wherein R₄ is:(a) --CO₂ H; (b) --CO₂ R₆ ; (c) --CONR₇R₈ ; and wherein R₇ and R₈ are:(a) hydrogen; (b) alkyl of 1 to 6 carbonatoms, inclusive; R₇ and R₈ each being the same or different; or thepharmacologically acceptable addition salts thereof.